| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atyr Pharma Inc (ATYR) has 4 insiders with recent SEC Form 4 filings, including 5 buys and 7 sells. ATYR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.50M | $1.42M | - | |
| Dir | 1.41M | $1.33M | - | |
| CFO | 412.5K | $389.2K | - | |
| Other | 412.5K | $389.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2021 | Schimmel Paul53 | Director | Buy | 250,000 | $8.00 | $2,000,000.00 | +8,651% | -22.3% | -71.3% | |
| May 21, 2021 | Clarke John K | Director | Sell | 2,500 | $4.34 | $10,850.00 | -2.3% | +1.6% | -32.6% | |
| May 18, 2021 | Shukla Sanjay66 | President And CEO | Buy | 10,000 | $4.01 | $40,100.00 | +120.5% | +18.4% | -24.2% | |
| May 18, 2021 | Schimmel Paul53 | Director | Buy | 50,000 | $3.98 | $199,000.00 | +79.3% | +18.4% | -24.2% | |
| Feb 9, 2021 | Broadfoot Jill Marie61 | Chief Financial Officer | Sale+OE | 390 | $7.66 | $2,987.40 | -3.8% | -50.3% | -21.4% | |
| Feb 9, 2021 | Shukla Sanjay66 | President And CEO | Sale+OE | 778 | $7.66 | $5,959.48 | -8.6% | -50.3% | -21.4% | |
| Sep 2, 2020 | Clarke John K | Director | Sell | 7,360 | $4.01 | $29,512.60 | -3.1% | - | - | |
| Aug 27, 2020 | Clarke John K | Director | Sell | 7,640 | $4.15 | $31,700.80 | -3.1% | - | - | |
| Jun 19, 2020 | Broadfoot Jill Marie61 | Chief Financial Officer | Buy | 1,850 | $4.22 | $7,807.00 | +25.3% | - | - | |
| Jun 19, 2020 | Shukla Sanjay66 | President And CEO | Buy | 6,000 | $4.27 | $25,620.00 | +464.8% | - | - |